Whitepapers
Microsoft Word - D2231-127 ApneaLink Plus White Paper.doc
ResMed Ltd 1 Elizabeth Macarthur Drive, Bella Vista NSW 2153 Australia Tel: +61 2 8884 1000 Fax: +61 2 8883 3114 ABN 30 003 765 142 Page 1 of 11 Global leaders in sleep and respiratory medicine www.resmed.com Title: APNEALINKTM PLUS WHITE PAPER Project/Product: APNEALINK PLUS DIAGNOSTIC DEVICE
British Medical Journal Report Supports SCHS White Paper ... ( WASHINGTON July 8 -- The result...)
Health,... ...WASHINGTON July 8 -- The results of a study p... ...The report concluded In patients without established cardiovascular ...,British,Medical,Journal,Report,Supports,SCHS,White,Paper,on,Statins,medicine,medical news today,latest medical news,medical newsletters,current medical
self-referral_to_physiotherapy - final
Making the most of evaluation 1 Self-referral to physiotherapy Chris Salisbury on behalf of the ‘Making the Most of Evaluation’ research group Background The concept of self-referral (without referral from a GP) for NHS services gained momentum during the 1990s. The White Paper ‘Our Health our care
BWT 102110 -- Aastrom Files SPA.indd
B I O T E C H ’ S M O S T R E S P E C T E D N E W S S O U R C E F O R 2 0 Y E A R S THURSDAY OCTOBER 21 , 2010 VOLUME 21 , NO. 204 SPECIAL REPRINT To subscribe, please call BIOWORLD® Customer Service at (800) 688-2421; outside the U.S. and Canada, call (404) 262-5476. Copyright © 2010 AHC Media
Meeting Description Title Slide
ASCO June 2011 Phase I Dose Escalation Study of ALN-VSP02 A Novel RNAi Therapeutic for Solid Tumors with Liver Involvement June 4, 2011 Mechanism for RNA Interference (RNAi) 2 mRNA mRNA degradation dsRNA dicer Cleavage Strand separation Complementary pairing Cleavage (A)n (A)n Synthetic siRNA
Microsoft Word - SBI Final White Paper final version for posting 6-18-11 _2_.doc
Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silicone outer shell and a filler (most commonly silicone gel..
LUKPM Care Closer to Home
Making the most of evaluation 1 Care Closer to Home Sarah Purdy on behalf of the ‘Making the Most of Evaluation’ research group Background In England the 2006 White Paper ‘Our health, our care, our say: A new direction for community services’ identified a need to move from health and social care
Corporate Overview September 2011 Alnylam Forward Looking Statements This presentation contains...
Corporate Overview September 2011 Alnylam Forward Looking Statements This presentation contains forward-looking statements. There are a number of important factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements. These important
Hemophilia Program Unmet Need and Product Opportunity
Hemophilia Program Unmet Need and Product Opportunity RNAi to treat hemophilia Hemophilias are recessive X-linked monogenic bleeding disorders » Hemophilia A defined by loss of function mutations in Factor VIII – >40,000 Patients in EU/US » Hemophilia B defined by loss of function mutations in
JP Morgan Healthcare Conference
Alnylam RNAi Roundtable May 13, 2011 Agenda & Introductions Welcome Cynthia Clayton » Senior Director, Investor Relations and Corporate Communications Program Overview Akshay Vaishnaw, M.D., Ph.D. (Moderator) » Senior Vice President, Clinical Research Jared Gollob, M.D. » Senior Director, Clinical
Refine by Content Type:
Refine by Source:
- www.alnylam.com (6)
- ukpolicymatters.thelancet.com (2)
- www.aastrom.com (1)
- www.bio-medicine.org (1)
- www.fda.gov (1)
- www.resmed.com (1)
